
Life Sciences
Data-driven business goes into overdrive
Consultancy and digital solutions
For pharma and biotech
The pharmaceutical and biotech industries have been put under the spotlight in an unprecedented way over the last year and this shows no sign of abating. There is increased pressure to find solutions to today’s healthcare and societal issues which will have an impact on future economies and people’s quality of life.
Atos can support you with a full range of expertise and services to enrich and streamline virtually every process in your research, production and delivery value chain, bringing you expertise combined with best in class innovation and security.
US $ 1.5 trillion
Global pharma spending will hit $1.5 trillion in 2023, says IQVIA, at a growth rate of 4-5%
Source: Pharmaceutical Commerce 2019
$US 13 billion
The global market for surgical robots is estimated to reach nearly US$13 billion in 2025
For medical device design and manufacturing
The life sciences sector is at the forefront of the international drive to develop new vaccines and therapeutics. There is increased pressure to find solutions to today’s healthcare and societal issues which will have an impact on future economies and people’s quality of life. On top of this, medical devices organizations are facing growing competition and, therefore, pressure to reduce costs and improve efficiencies.
Atos can support you with a full range of expertise and services to enrich and streamline virtually every process in your research, production and delivery value chain, bringing you expertise combined with best in class innovation and security.
Key challenges
Pharma & biotech >
Pharmaceutical and biotech key challenges
Reduce operational cost
Drive productivity
Improve quality and compliance
Medical devices >
Medical devices key challenges
Drive productivity
Improve quality and compliance
Reduce operational cost
Our experts

Patrick Bajard
Head of Healthcare & Life Sciences
– Central & Eastern Europe
